Jamille E R S Santana, Maria Luiza Carvalho, Tiago da Silva Lopes, José G V Miranda, Pedro Montoya, Abrahão F Baptista, André Fonseca
{"title":"Distinct Brain Connectivity Patterns in Sickle Cell Disease: A Biomarker for Chronic Pain Severity.","authors":"Jamille E R S Santana, Maria Luiza Carvalho, Tiago da Silva Lopes, José G V Miranda, Pedro Montoya, Abrahão F Baptista, André Fonseca","doi":"10.1089/brain.2024.0087","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Central nervous system complications are common in sickle cell disease (SCD), and the defining associated biomarkers are becoming increasingly relevant for physicians in diagnostic and prognostic contexts. Recent studies have reported altered brain connectivity in pain processing, highlighting a new avenue for developing sensitive measures of SCD severity. <b><i>Method:</i></b> This cross-sectional study used graph theory concepts to analyze effective connectivity in individuals with SCD and healthy controls during rest and motor imagery tasks. The SCD group was further divided into two subgroups based on pain intensity (less pain or more pain) during the evaluation. <b><i>Results:</i></b> Individuals with SCD and chronic pain exhibited a distinct brain connectivity signature compared to healthy individuals and within pain sublevels. <b><i>Conclusion:</i></b> Chronic pain in SCD shows a unique brain connectivity pattern when compared to healthy subjects and across different pain levels. The results support the hypothesis that chronic pain condition is associated with decreased interhub connections and increased intrahub connections for specific brain rhythms. Furthermore, the small-world parameter can distinguish SCD individuals from controls and differentiate pain levels within SCD individuals, offering a promising biomarker for clinical assessment.</p>","PeriodicalId":9155,"journal":{"name":"Brain connectivity","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain connectivity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/brain.2024.0087","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Central nervous system complications are common in sickle cell disease (SCD), and the defining associated biomarkers are becoming increasingly relevant for physicians in diagnostic and prognostic contexts. Recent studies have reported altered brain connectivity in pain processing, highlighting a new avenue for developing sensitive measures of SCD severity. Method: This cross-sectional study used graph theory concepts to analyze effective connectivity in individuals with SCD and healthy controls during rest and motor imagery tasks. The SCD group was further divided into two subgroups based on pain intensity (less pain or more pain) during the evaluation. Results: Individuals with SCD and chronic pain exhibited a distinct brain connectivity signature compared to healthy individuals and within pain sublevels. Conclusion: Chronic pain in SCD shows a unique brain connectivity pattern when compared to healthy subjects and across different pain levels. The results support the hypothesis that chronic pain condition is associated with decreased interhub connections and increased intrahub connections for specific brain rhythms. Furthermore, the small-world parameter can distinguish SCD individuals from controls and differentiate pain levels within SCD individuals, offering a promising biomarker for clinical assessment.
期刊介绍:
Brain Connectivity provides groundbreaking findings in the rapidly advancing field of connectivity research at the systems and network levels. The Journal disseminates information on brain mapping, modeling, novel research techniques, new imaging modalities, preclinical animal studies, and the translation of research discoveries from the laboratory to the clinic.
This essential journal fosters the application of basic biological discoveries and contributes to the development of novel diagnostic and therapeutic interventions to recognize and treat a broad range of neurodegenerative and psychiatric disorders such as: Alzheimer’s disease, attention-deficit hyperactivity disorder, posttraumatic stress disorder, epilepsy, traumatic brain injury, stroke, dementia, and depression.